SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-015738
Filing Date
2020-11-05
Accepted
2020-11-05 16:10:56
Documents
18
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20201105.htm   iXBRL 8-K 32452
2 EX-99.1 exhibit991adverum3q20p.htm EX-99.1 30327
8 GRAPHIC image1a.jpg GRAPHIC 37469
9 GRAPHIC image2a.jpg GRAPHIC 50646
10 GRAPHIC image_01a.jpg GRAPHIC 239882
  Complete submission text file 0001628280-20-015738.txt   662222

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20201105.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20201105_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20201105_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20201105_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20201105_pre.xml EX-101.PRE 12644
11 EXTRACTED XBRL INSTANCE DOCUMENT advm-20201105_htm.xml XML 10511
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 201290534
SIC: 2836 Biological Products, (No Diagnostic Substances)